TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Determination of brain death
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of Adverse Events (AEs) or Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Microbial Diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbial Signature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spinal Anaesthesia Anxiety and Agitation Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Well-being Numerical Rating Scales
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Job Burnout
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of reactions (local)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of reactions (systemic)
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of reactions (local and systemic)
Endpoint domain: Adverse events/effects
Primary endpoint: Testicular Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Testicular Self-Examination Behaviour
Endpoint domain: Life impact
Endpoint subdomain: Health-related behaviour
Primary endpoint: Modified plaque index (PI-M)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bladder retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Lung tumor fractional synthetic rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Lung tissue fractional synthetic rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle tissue fractional synthetic rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Presence of myeloid mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Tumor response evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Post-transplant Acute Kidney Injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: concentration of Exosome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alzheimer's Disease Assessment Scale-Cognitive Subscale scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Behavioural and Psychological Symptoms of Dementia scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall user experience
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in knowledge of acute cholecystitis and pancreatitis
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: NAD+ Levels in the Blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Progression from AKI Stage 1-2 to Stage 3 within 14 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in vertical and volumetric loss of splint material
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first negative SARS-CoV-2 PCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Time to first negative Mycobacterium tuberculosis sputum culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: cellular profile in skeletal muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Toddler's Body Mass index (BMI) percentile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in parent's Body Mass index (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Antibiotic prescription at index visit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Activity intolerance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time spent in age-predicted maximum high-intensity target heart rate zone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent in age-predicted moderate-intensity target heart rate zone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent in age-predicted low-intensity target heart rate zone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of the Computer Assessed Guide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overactive Bladder Questionnaire (OAB-q)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients with neuropathic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Therapeutic potential of ADM inhibition on leukaemia stem cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Smell loss improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle activation (%MVIC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Ankle stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in patient reported psychological distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in reported PRO-CTCAE Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain at Site of Injection
Endpoint domain: Adverse events/effects
Primary endpoint: Tenderness at Site of Injection
Endpoint domain: Adverse events/effects
Primary endpoint: Erythema at Site of Injection
Endpoint domain: Adverse events/effects
Primary endpoint: Swelling at Site of Injection
Endpoint domain: Adverse events/effects
Primary endpoint: Lens Fit Acceptance Rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Edmonton Symptoms Assessments System (ESAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Italian Integrated Palliative Care Outcome Scale (IPOS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Letter & Pattern Comparison (LPC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Radiologic Determination of Bone Fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in vegetable and fruit consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence rate of surgical site infection
Endpoint domain: Adverse events/effects
Primary endpoint: Edema Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dentin hypersensitivity level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neutralizing Antibodies in Serum against Live SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Binding Antibodies in Serum against SARS-CoV-2 RBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pulmonary Vascular Resistance (PVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Maximal diaphragm tissue velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transdiaphragmatic twitch pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe perinatal morbidity
Endpoint domain: Mortality/survival
Primary endpoint: Session Adherence
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Deltoid and Quadriceps Femoris Muscle Oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deltoid and Quadriceps Femoris Muscle Total Hemoglobin Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day postoperative mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Resting Motor Threshold (rMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Motor Evoked Potential (MEP) Latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Motor Evoked Potential (MEP) amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Double-leg vertical jump test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of near-falls
Endpoint domain: Adverse events/effects
Primary endpoint: Average diagnostic accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of intraoperatively identified parathyroid glands
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: anti-gE antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CB1R Availability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance characteristics (sensitivity, specificity, PPV, NPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circadian rhythm disturbances
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Alteration of total sleep time
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Frequency of select safety events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in maximum voided volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in mean office systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in clinical laboratory test parameters, vital signs, neurological examination abnormalities and ECG abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Short Form-36 (SF-36) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: maximum subjective pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage reduction in ablation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prevalence of obstetric anal sphincter injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Respiratory Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Complete Pathologic Response (CPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSA30 response at end-of-treatment (EOT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in frequency of circulating ALDHhiSSChi granulocyte precursor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Sexual Dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients who Experience Dose-Limiting Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of complete aneurysm occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Achievement of diarrhoea control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean change in General Self-Rated Health Visual Analog Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent improved on Gulf War Illness Modified Lower Extremity Performance Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of symptoms showing more favorable change on active treatment vs. placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of annual uses of the intraoperative blood recovery system
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Morphine Milligram Equivalents Use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of Grade 3 or 4 Possibly related adverse events (PRAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with laboratory-confirmed pulmonary tuberculosis
Endpoint domain: Mortality/survival
Primary endpoint: Volume Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diameter Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean of number of occurred ADEs
Endpoint domain: Adverse events/effects
Primary endpoint: Montreal Cognitive Assessment Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: World Health Organization Quality of Life Brief Version (WHO-QOL BREF) Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in upper limb motor activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the evaluation of achievement of the patient's rehabilitation objectives using the Goal Attainment Scale (GAS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Received a living donor kidney transplant
Endpoint domain: Mortality/survival
Primary endpoint: Received a deceased donor kidney transplant
Endpoint domain: Mortality/survival
Primary endpoint: Event rate of major adverse cardiac or cerebrovascular events
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rate of low-back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rate of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Rate of neck pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rate of dyspnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of joint pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: proportion of participants that complete the study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: proportion of participants that consent who are approached for the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: proportion of participants who state the intervention is acceptable during a qualitative interview
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intra- and inter-observer reproducibility of anatomical measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe-Toxicity-Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Number of different Severe Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Complete or Partial Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EVD Placement Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Kidney transplant understanding tool (K-TUT)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-care in chronic illness inventory v.4c
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The Self-Efficacy for Managing Chronic Disease 6-item Scale (SES6G)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pearlin Mastery Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The Depression Anxiety Stress Scales 21 (DASS-21)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Acceptance of chronic health conditions scale (ACHC)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Risk of developing Gastric Cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Geriatric Locomotive Function Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of I-FABP values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Total Knowledge Score of Screening Mammography Guidelines
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in MADRS Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in DARS Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived Thirst Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intradialytic Weight Gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportions of patients with exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of Serotonin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Level of Dopamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Curative rate of otomycosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emory Functional Ambulation Profile score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Margin of Stability (MoS) (cm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed-Up-And-Go test (TUG) score (s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in time to antibiotic administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Five years overall survival
Endpoint domain: Mortality/survival
Primary endpoint: Rates of axillary lymph node dissection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Levels of immune effectors (Tcells, NK)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pain score in post op period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of TB Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Forced Vital Capacity (FVC) After 12 Weeks of Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change From Baseline in Forced Vital Capacity (FVC) After 24 Weeks of Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Convulsion Quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Change in Medication adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in fasting serum/plasma concentrations of C-reactive protein (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average length of speech elicitation (in seconds)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of children and adolescents achieving viral suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to viral suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Catheter-related blood stream infection rates
Endpoint domain: Adverse events/effects
Primary endpoint: Catheter colonization rates
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of COPD patients with medication-comorbidity clashes
Endpoint domain: Adverse events/effects
Primary endpoint: Uptake of Talk About It
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Medications for Opioid Use Disorder (MOUD) initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability/Feasibility of Talk About It
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Standardized Uptake Value Ratio (SUVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of adverse birth outcomes
Endpoint domain: Mortality/survival
Primary endpoint: Birth defects per trimester of exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cumulative incidence and kinetics of neutrophil and platelet recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Maximum plasma concentration (Cmax) of SSS17
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve (AUC) of plasma concentration of SSS17
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-to-Cmax (Tmax) of SSS 17
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants who do not opt out of receipt of text messages
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of participants who said texts were helpful as measured by questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of participants who would refer a friend/family to the texting program
Endpoint domain: Life impact
Endpoint subdomain: Social functioning